PortfoliosLab logoPortfoliosLab logo
AMPY vs. APYX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AMPY vs. APYX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amplify Energy Corp. (AMPY) and Apyx Medical Corporation (APYX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AMPY achieves a -14.00% return, which is significantly lower than APYX's 16.57% return.


AMPY

1D
-2.72%
1M
-21.56%
YTD
-14.00%
6M
-18.30%
1Y
12.61%
3Y*
-15.27%
5Y*
-1.55%
10Y*
20.83%

APYX

1D
1.75%
1M
-1.21%
YTD
16.57%
6M
13.33%
1Y
104.00%
3Y*
-17.63%
5Y*
-17.35%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

AMPY vs. APYX - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
AMPY
Amplify Energy Corp.
-14.00%-23.83%1.18%-32.54%182.64%137.40%-77.85%-5.47%
APYX
Apyx Medical Corporation
16.57%121.52%-39.69%11.97%-81.75%78.06%-14.89%6.28%

Correlation

The correlation between AMPY and APYX is -0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.03

Correlation (3Y)
Calculated over the trailing 3-year period

0.02

Correlation (5Y)
Calculated over the trailing 5-year period

0.07

Correlation (All Time)
Calculated using the full available price history since Jan 2, 2019

0.13

The correlation between AMPY and APYX shifts across timeframes, from -0.03 (1 year) to 0.13 (all time), reflecting how their relationship changes across market environments.

Fundamentals

EPS

AMPY:

$0.29

APYX:

-$0.30

PS Ratio

AMPY:

0.70

APYX:

2.26

Total Revenue (TTM)

AMPY:

$228.78M

APYX:

$55.83M

Gross Profit (TTM)

AMPY:

$131.23M

APYX:

$21.29M

EBITDA (TTM)

AMPY:

$84.62M

APYX:

-$3.18M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AMPY vs. APYX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AMPY
AMPY Risk / Return Rank: 5050
Overall Rank
AMPY Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
AMPY Sortino Ratio Rank: 5050
Sortino Ratio Rank
AMPY Omega Ratio Rank: 4848
Omega Ratio Rank
AMPY Calmar Ratio Rank: 5050
Calmar Ratio Rank
AMPY Martin Ratio Rank: 5252
Martin Ratio Rank

APYX
APYX Risk / Return Rank: 7979
Overall Rank
APYX Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
APYX Sortino Ratio Rank: 7878
Sortino Ratio Rank
APYX Omega Ratio Rank: 7575
Omega Ratio Rank
APYX Calmar Ratio Rank: 8383
Calmar Ratio Rank
APYX Martin Ratio Rank: 8282
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AMPY vs. APYX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amplify Energy Corp. (AMPY) and Apyx Medical Corporation (APYX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


AMPYAPYXDifference
Sharpe ratioReturn per unit of total volatility

-1.00

Sortino ratioReturn per unit of downside risk

-1.37

Omega ratioGain probability vs. loss probability

1.09

1.25

-0.16

Calmar ratioReturn relative to maximum drawdown

0.31

2.86

-2.55

Martin ratioReturn relative to average drawdown

0.75

6.86

-6.11

AMPY vs. APYX - Sharpe Ratio Comparison

The current AMPY Sharpe Ratio is 0.19, which is lower than the APYX Sharpe Ratio of 1.19. The chart below compares the historical Sharpe Ratios of AMPY and APYX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

AMPY vs. APYX - Drawdown Comparison

The maximum AMPY drawdown since its inception was -97.31%, roughly equal to the maximum APYX drawdown of -94.99%. Use the drawdown chart below to compare losses from any high point for AMPY and APYX.


Loading charts...

Drawdown Indicators


AMPYAPYXDifference

Max Drawdown

Largest peak-to-trough decline

-97.31%

-94.99%

-2.32%

Max Drawdown (1Y)

Largest decline over 1 year

-40.72%

-36.59%

-4.13%

Max Drawdown (3Y)

Largest decline over 3 years

-71.11%

-88.52%

+17.41%

Max Drawdown (5Y)

Largest decline over 5 years

-77.47%

-94.99%

+17.52%

Max Drawdown (10Y)

Largest decline over 10 years

-97.24%

Current Drawdown

Current decline from peak

-79.17%

-76.55%

-2.62%

Average Drawdown

Average peak-to-trough decline

-66.43%

-57.06%

-9.37%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.90%

15.21%

+1.69%

Volatility

AMPY vs. APYX - Volatility Comparison

The current volatility for Amplify Energy Corp. (AMPY) is 13.45%, while Apyx Medical Corporation (APYX) has a volatility of 22.15%. This indicates that AMPY experiences smaller price fluctuations and is considered to be less risky than APYX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AMPYAPYXDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.45%

22.15%

-8.70%

Volatility (6M)

Calculated over the trailing 6-month period

40.40%

55.41%

-15.01%

Volatility (1Y)

Calculated over the trailing 1-year period

65.19%

87.90%

-22.71%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

67.18%

100.40%

-33.22%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

980.58%

93.04%

+887.54%

Dividends

AMPY vs. APYX - Dividend Comparison

Neither AMPY nor APYX has paid dividends to shareholders.


PositionTTM2025202420232022202120202019
AMPY
Amplify Energy Corp.
0.00%0.00%0.00%0.00%0.00%0.00%7.63%6.05%
APYX
Apyx Medical Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

AMPY vs. APYX - Financials Comparison

This section allows you to compare key financial metrics between Amplify Energy Corp. and Apyx Medical Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00M100.00M120.00M20222023202420252026
37.46M
12.42M
(AMPY) Total Revenue
(APYX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


AMPY and APYX have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

APYX has higher volatility (22.15%) compared to AMPY (13.45%). In terms of maximum drawdown, AMPY dropped -97.31% vs APYX's -94.99%.

APYX currently has the higher Sharpe Ratio (1.19 vs 0.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AMPY and APYX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer